Back to Search
ROBERT SHALWITZ, M.D.
M.D.
Pediatrics Physician
NPI: 1235527219Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
35.071838(OH)
Pediatric Endocrinology Physician
Pediatrics — Pediatric Endocrinology
Code: 2080P0205X
35.071838(OH)
Research & Publications (8)
A randomized, double-blind, placebo-controlled trial on intravenous ibuprofen L-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants.
PMID 19067286·Am J Perinatol·2009
4-observational
Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
PMID 17825687·Clin Ther·2007
4-observational
Study of the pharmacokinetic interaction between simvastatin and prescription omega-3-acid ethyl esters.
PMID 16809804·J Clin Pharmacol·2006
2-rct
Health effects of ultraviolet irradiation in asthmatic children's homes.
PMID 16809237·J Asthma·2006
4-observational
Effects of fenofibrate on atherogenic dyslipidemia in hypertriglyceridemic subjects.
PMID 16796078·Clin Cardiol·2006
4-observational
Comparison of treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome.
PMID 14628142·Eur J Pediatr·2004
4-observational
Lactoferrin protects neonatal rats from gut-related systemic infection.
PMID 11668022·Am J Physiol Gastrointest Liver Physiol·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2549 BRYDEN RD
BEXLEY, OH 43209 - Phone
- (614) 715-1860
Quick Facts
- NPI
- 1235527219
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile